The Kaleidoscope Brief

Across the ~760 institutions we track as "notable," the single largest net purchase of Q1 was +$5.97B into Aflac (AFL) — and every one of the four funds behind it opened a brand-new position rather than adding to an old one. The megacaps saw the broader accumulation you'd expect, each from seven fresh notable holders:

Celcuity (CELC) faces a PDUFA decision on July 17 — six days out — for gedatolisib in HR+/HER2−/PIK3CA-wild-type advanced breast cancer, on a priority review. Our date-confidence: 95%. Right behind it, Sanofi's Dupixent decision in chronic spontaneous urticaria lands July 23 (recently extended).

Over the last 180 days the busiest buyer in private markets wasn't a PE megafund — it was Inszone Insurance Services, which quietly closed 19 acquisitions (Sanford Bruker & Banks, Sommelier, Legacy Partners, and 16 more, all undisclosed). A textbook insurance-brokerage roll-up, running at roughly a deal every nine days — and invisible to anything trained on public filings.

Of the corporate debt maturing in 2028 that bond funds actually hold, the largest single non-financial issuer is Western Digital — $1.25B in one 3%-coupon bond, a rate that made sense in a different cycle. It out-walls the money-center banks:

The prints that move rates and the curve this week: